DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Smith MR, Thomas S, Chowdhury S. et al.
Abstract 2605: Androgen receptor (AR) anomalies and efficacy of apalutamide (APA) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from the phase 3 SPARTAN study.
Cancer Research 2018;
78: 2605-2605
DOI: 10.1158/1538-7445.am2018-2605.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.